I have thought about this "survivor" and "cash out"possibility for awhile. Honestly, I don't believe we are in survivor mode as I have been adding as growth(labs) is accelerating and currently just not in the survivor mode but ratcheting up to thriving with opportunities.
In the event they continue any type of toxic financing and virtually just over pay without relevant revenue increases in established markets such as Oregon is survivor mode. Basically stating lab revenues are stagnant on existing labs. At that point we merely become a "survivor" and acquisitions and new mergers begin to stop. Coming to a value IMO, is going to be challenging as they are building a foot print that really is desirable as a buyout candidate. If they complete 18 labs by year end and significant revenues are not obvious I believe $3.00 based on they still have an absolute footprint and licenses amassed. With vastly improving revenues $5+
In conclusion $3.00 on the survivor value providing we have 18 labs year end. Much higher if significant revenue increase is obvious. WW talking like 2019 or after Sept. 30 is the break out year.
News 
Market Data 
Discover 
